Literature DB >> 14900966

The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.

P A OWREN, K AAS.   

Abstract

Entities:  

Keywords:  COUMARIN/therapeutic use

Mesh:

Substances:

Year:  1951        PMID: 14900966     DOI: 10.3109/00365515109060600

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  80 in total

1.  Prothrombin complex concentrate: use in controlling the hemorrhagic diathesis of chronic liver disease.

Authors:  R L Bick; W R Schmalhorst; E Shanbrom
Journal:  Am J Dig Dis       Date:  1975-08

2.  CONTROL OF ANTICOAGULANT THERAPY: POSTAL COMPARISON BETWEEN FIVE CENTRES.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

3.  STUDIES ON TYROSINOSIS: 1, EFFECT OF LOW-TYROSINE AND LOW-PHENYLALANINE DIET.

Authors:  S HALVORSEN; L R GJESSING
Journal:  Br Med J       Date:  1964-11-07

4.  ACTIVATION PRODUCT, FACTOR IX, SERUM THROMBOTIC ACCELERATOR ACTIVITY, AND SERUM-INDUCED THROMBOSIS.

Authors:  D DEYKIN; S WESSLER
Journal:  J Clin Invest       Date:  1964-02       Impact factor: 14.808

5.  THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. I. EVIDENCE FOR THE PROPERTIES OF A NEW SERUM THROMBOPLASTIC FACTOR.

Authors:  R COLMAN; B ALEXANDER
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

6.  [THE ALTERATION OF BLOOD COAGULATION BY PLASTIC MONOMERS AND PRIMARY POLYMERISATES].

Authors:  R WERNER
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1963-11-05

7.  THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. II. ASSAY OF A NEW SERUM THROMBOPLASTIC FACTOR VULNERABLE TO THESE ELEMENTS AND ITS VARIATIONS IN HEALTH AND DISEASE.

Authors:  R COLMAN; B ALEXANDER
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

8.  LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.

Authors:  S SHAW; G D PEGRUM; S WOLFF
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

9.  Comparison between the polymyxins and gentamicin in preventing endotoxin-induced intravascular coagulation and leukopenia.

Authors:  J J Corrigan; B M Bell
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

Review 10.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.